PillSeek

Reviewed by PillSeek Editorial Team · Last updated

Complera

Emtricitabine 200 mg;rilpivirine hydrochloride 25 mg;tenofovir disoproxil fumarate 300 mg;

About This Medication

This medication is a Purple Oval 19 mm, Film coated tablet with imprint "GSI". It contains Emtricitabine 200 mg;rilpivirine hydrochloride 25 mg;tenofovir disoproxil fumarate 300 mg; of Emtricitabine[emtricitabine];rilpivirine hydrochloride[rilpivirine];tenofovir disoproxil fumarate[tenofovir anhydrous];. This belongs to the Human immunodeficiency virus 1 non-nucleoside analog reverse transcriptase inhibitor pharmacologic class. It is manufactured by Gilead Sciences, Inc.. For details please contact your physician.

Basic Information

Imprint
GSI
Color
Purple
Shape
Oval
Size
19 mm

Drug Information

Strength
Emtricitabine 200 mg;rilpivirine hydrochloride 25 mg;tenofovir disoproxil fumarate 300 mg;
Dosage Form
Film coated tablet
RxCUI
1147337

Related Medications

Other drugs in the same class: Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor

Ingredients

Active Ingredients
Emtricitabine[emtricitabine];rilpivirine hydrochloride[rilpivirine];tenofovir disoproxil fumarate[tenofovir anhydrous];
Inactive Ingredients
Microcrystalline cellulose;lactose monohydrate;povidone, unspecified;polysorbate 20;croscarmellose sodium;magnesium stearate;starch, corn;hypromellose, unspecified;fd&c blue no. 2;aluminum oxide;polyethylene glycol, unspecified;ferric oxide red;titanium dioxide;triacetin;fd&c yellow no. 6;

Additional Information

Manufacturer
Gilead Sciences, Inc.
Status (Rx/OTC)
Rx
Brand Names
Complera

⚠️ Important: This information is for educational purposes only. Do not use this tool for medical diagnosis or treatment decisions. Always consult your pharmacist or healthcare provider for questions about your medications. Read full medical disclaimer.

Purple Oval Complera Emtricitabine 200 mg;rilpivirine hydrochloride 25 mg;tenofovir disoproxil fumarate 300 mg; Pill With Imprint GSI | PillSeek